European Health Investor Network’s Post

Optimist but realist Reflecting on a challenging year, we are hopeful that 2024 holds the promise of a brighter future. Whether you're an optimist or not, the strides made in the VC/PE and Startup landscape are setting the stage for positive change but it will take time. According to #Pitchbook, Biopharma companies will require more solid clinical validation and see longer fundraising time, Surgical robotics should surpass 2023 funding levels, Digital Health and AI will continue to disrupt our healthcare systems though valuation may go down. Startups must navigate carefully, adjusting their strategies to optimize cash flow while initiating early fundraising efforts. The competition will be intense, but those who adapt and innovate will emerge victorious. Here's to a resilient startup ecosystem and a market that regains its stability in the upcoming year!

  • No alternative text description for this image

Always working towards better health

  • No alternative text description for this image
Like
Reply

To view or add a comment, sign in

Explore topics